The page is the record's research on the issuer — no analyst, no rating, no view.

# LIGAND PHARMACEUTICALS INC (NASDAQ: LGND) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is LIGAND PHARMACEUTICALS INC, listed on NASDAQ under ticker LGND, with ISIN US53220K5048 and LEI 5493008K7TB0IKP37H79. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.

## The disclosure read

The record holds 119 filings in the twelve months to 2026-11-08, across 77 filing days. The median gap between filing days is 2.5 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type directors_dealings. The NASDAQ exchange median is 52 filings, a median cadence gap of 6.0 days, and a median latency of 5.0 days. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, a median cadence gap of 6.0 days, and a median latency of 4.0 days.

## Auditor

The auditor of record is Ernst & Young LLP, located in San Diego, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting, name change or segment move events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations page.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date for the US market is 2021-01-04, and the live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0000886163.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/LGND (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/LGND (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/LGND · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp